Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Copeland

Showing results (551-560 of 573) with videos related to

Pageof 58
Sort By:
Genome Announcements|January 24, 2015
Complete Genome Sequence of Anaeromyxobacter sp. Fw109-5, an Anaerobic, Metal-Reducing Bacterium Isolated from a Contaminated Subsurface EnvironmentC Hwang, A Copeland, S Lucas, et al.
Scientific Reports|December 23, 2017
Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple MyelomaAllison E Drew, Oscar Moradei, Suzanne L Jacques, et al.
Cancer Research|April 3, 2008
Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activityNelson Rhodes, Dirk A Heerding, Derek R Duckett, et al.
Biorxiv : the Preprint Server for Biology|November 16, 2022
Towards increased accuracy and reproducibility in SARS-CoV-2 next generation sequence analysis for public health surveillanceRyan Connor, David A Yarmosh, Wolfgang Maier, et al.
Viruses|March 28, 2024
Recommendations for Uniform Variant Calling of SARS-CoV-2 Genome Sequence across Bioinformatic WorkflowsRyan Connor, Migun Shakya, David A Yarmosh, et al.
Journal of Bacteriology|October 19, 2010
Genome sequence of the obligate methanotroph Methylosinus trichosporium strain OB3bLisa Y Stein, Sukhwan Yoon, Jeremy D Semrau, et al.
Chemistry & Biology|February 23, 2011
Discovery and characterization of a cell-permeable, small-molecule c-Abl kinase activator that binds to the myristoyl binding siteJingsong Yang, Nino Campobasso, Mangatt P Biju, et al.
Molecular Cancer Therapeutics|February 25, 2014
Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphomaSarah K Knutson, Satoshi Kawano, Yukinori Minoshima, et al.
Molecular Cancer Therapeutics|May 18, 2005
Matrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicityCharles F Albright, Nilsa Graciani, Wei Han, et al.
The Journal of Biological Chemistry|August 7, 1999
Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS familyI Abbaszade, R Q Liu, F Yang, et al.
Pageof 58

Showing results (551-560 of 573) with videos related to

Sort By:
Pageof 58
Genome Announcements|January 24, 2015
Complete Genome Sequence of Anaeromyxobacter sp. Fw109-5, an Anaerobic, Metal-Reducing Bacterium Isolated from a Contaminated Subsurface EnvironmentC Hwang, A Copeland, S Lucas, et al.
Scientific Reports|December 23, 2017
Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple MyelomaAllison E Drew, Oscar Moradei, Suzanne L Jacques, et al.
Cancer Research|April 3, 2008
Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activityNelson Rhodes, Dirk A Heerding, Derek R Duckett, et al.
Biorxiv : the Preprint Server for Biology|November 16, 2022
Towards increased accuracy and reproducibility in SARS-CoV-2 next generation sequence analysis for public health surveillanceRyan Connor, David A Yarmosh, Wolfgang Maier, et al.
Viruses|March 28, 2024
Recommendations for Uniform Variant Calling of SARS-CoV-2 Genome Sequence across Bioinformatic WorkflowsRyan Connor, Migun Shakya, David A Yarmosh, et al.
Journal of Bacteriology|October 19, 2010
Genome sequence of the obligate methanotroph Methylosinus trichosporium strain OB3bLisa Y Stein, Sukhwan Yoon, Jeremy D Semrau, et al.
Chemistry & Biology|February 23, 2011
Discovery and characterization of a cell-permeable, small-molecule c-Abl kinase activator that binds to the myristoyl binding siteJingsong Yang, Nino Campobasso, Mangatt P Biju, et al.
Molecular Cancer Therapeutics|February 25, 2014
Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphomaSarah K Knutson, Satoshi Kawano, Yukinori Minoshima, et al.
Molecular Cancer Therapeutics|May 18, 2005
Matrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicityCharles F Albright, Nilsa Graciani, Wei Han, et al.
The Journal of Biological Chemistry|August 7, 1999
Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS familyI Abbaszade, R Q Liu, F Yang, et al.
Pageof 58